Etiket: EHA
ADC Therapeutics Announces Abstract Presentation at the 2022 European Hematology Association (EHA) Hybrid Congress
shares in this article ADC Therapeutics SA (NYSE: ADCT) today announced that results from the pivotal Phase 2 clinical trial of camidanlumab tesirine (Cami) in patients with relapsed or refractory…